You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 152 No. 7, JULY 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Impact of Human T-Lymphotrophic Virus Type I/II Infection on the Prognosis of Sexually Acquired Cases of Acquired Immunodeficiency Syndrome

Eduardo Gotuzzo, MD; Joel Escamilla, PhD; Irving A. Phillips; Jorge Sanchez, MD; F. Stephen Wignall, MD; Juana Antigoni, MD

Arch Intern Med. 1992;152(7):1429-1432.


Abstract

Twenty (18%) of 111 Peruvian men with sexually acquired human immunodeficiency virus infection were found also to be infected with human T-lymphotrophic virus type I or II in a retrospective study. At the time of data evaluation, 75 patients had reached Centers for Disease Control stage IV (clinical acquired immunodeficiency syndrome) and had not received antiviral medication; mortality in this group was 63.3% (38/60) among patients infected with human immunodeficiency virus alone and 80% (12/15) in the dually infected group. Of the 50 patients who had died, survival time from onset of stage IV to death was shorter in the dually infected group (5.02±3.27 months) than in those with human immunodeficiency virus infection alone (10.07±4.42 months). In Peru, sexually acquired human immunodeficiency virus infection in men is often accompanied by human T-lymphotrophic virus type I/II infection, and dual retrovirus infection is associated with a shorter survival after onset of clinical acquired immunodeficiency syndrome.

(Arch Intern Med. 1992;152:1429-1432)



Author Affiliations

From the "Alexander Von Humboldt" Institute of Tropical Medicine, Cayetano Heredia Peruvian University (Drs Gotuzzo and Sanchez), US Naval Medical Research Institute Detachment (Drs Escamilla and Wignall and Mr Phillips), and "Edgardo Rebagliati Martins" Hospital and National Program for the Control of AIDS, Health Ministry (Dr Antigoni), Lima, Peru.


Footnotes

Accepted for publication January 16, 1992.

Reprint requests to Universidad Peruana Cayetano Heredia, PO Box 5045, Lima 100, Peru (Dr Gotuzzo).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)-infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I-uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1
Moriuchi et al.
JEM 1998;187:1689-1697.
ABSTRACT | FULL TEXT  

Does Human T-Cell Lymphotropic Virus Type I and Human Immunodeficiency Virus Type 1 Coinfection Accelerate Acquired Immunodeficiency Syndrome? The Jury Is Still Out
Cleghorn and Blattner
Arch Intern Med 1992;152:1372-1373.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.